These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
456 related articles for article (PubMed ID: 20939055)
1. EP1(-/-) mice have enhanced osteoblast differentiation and accelerated fracture repair. Zhang M; Ho HC; Sheu TJ; Breyer MD; Flick LM; Jonason JH; Awad HA; Schwarz EM; O'Keefe RJ J Bone Miner Res; 2011 Apr; 26(4):792-802. PubMed ID: 20939055 [TBL] [Abstract][Full Text] [Related]
2. Osteoblast-Specific Loss of IGF1R Signaling Results in Impaired Endochondral Bone Formation During Fracture Healing. Wang T; Wang Y; Menendez A; Fong C; Babey M; Tahimic CG; Cheng Z; Li A; Chang W; Bikle DD J Bone Miner Res; 2015 Sep; 30(9):1572-84. PubMed ID: 25801198 [TBL] [Abstract][Full Text] [Related]
3. Low-dose X-ray irradiation promotes osteoblast proliferation, differentiation and fracture healing. Chen M; Huang Q; Xu W; She C; Xie ZG; Mao YT; Dong QR; Ling M PLoS One; 2014; 9(8):e104016. PubMed ID: 25089831 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of the Prostaglandin EP-1 Receptor in Periosteum Progenitor Cells Enhances Osteoblast Differentiation and Fracture Repair. Feigenson M; Jonason JH; Shen J; Loiselle AE; Awad HA; O'Keefe RJ Ann Biomed Eng; 2020 Mar; 48(3):927-939. PubMed ID: 30980293 [TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro. Choudhary S; Blackwell K; Voznesensky O; Deb Roy A; Pilbeam C Bone; 2013 Sep; 56(1):31-41. PubMed ID: 23639875 [TBL] [Abstract][Full Text] [Related]
6. A2B adenosine receptor promotes mesenchymal stem cell differentiation to osteoblasts and bone formation in vivo. Carroll SH; Wigner NA; Kulkarni N; Johnston-Cox H; Gerstenfeld LC; Ravid K J Biol Chem; 2012 May; 287(19):15718-27. PubMed ID: 22403399 [TBL] [Abstract][Full Text] [Related]
7. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Suzawa T; Miyaura C; Inada M; Maruyama T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Suda T Endocrinology; 2000 Apr; 141(4):1554-9. PubMed ID: 10746663 [TBL] [Abstract][Full Text] [Related]
8. SC-19220, antagonist of prostaglandin E2 receptor EP1, inhibits osteoclastogenesis by RANKL. Tsujisawa T; Inoue H; Nishihara T J Bone Miner Res; 2005 Jan; 20(1):15-22. PubMed ID: 15619665 [TBL] [Abstract][Full Text] [Related]
10. Compressive force induces osteoclast differentiation via prostaglandin E(2) production in MC3T3-E1 cells. Sanuki R; Shionome C; Kuwabara A; Mitsui N; Koyama Y; Suzuki N; Zhang F; Shimizu N; Maeno M Connect Tissue Res; 2010 Apr; 51(2):150-8. PubMed ID: 20001844 [TBL] [Abstract][Full Text] [Related]
11. The effect of deletion of cyclooxygenase-2, prostaglandin receptor EP2, or EP4 in bone marrow cells on osteoclasts induced by mouse mammary cancer cell lines. Ono K; Akatsu T; Kugai N; Pilbeam CC; Raisz LG Bone; 2003 Nov; 33(5):798-804. PubMed ID: 14623055 [TBL] [Abstract][Full Text] [Related]
12. Intact prostaglandin signaling through EP2 and EP4 receptors in stromal progenitor cells is required for normal development of the renal cortex in mice. Fuchs MAA; Schrankl J; Leupold C; Wagner C; Kurtz A; Broeker KA Am J Physiol Renal Physiol; 2022 Mar; 322(3):F295-F307. PubMed ID: 35037469 [TBL] [Abstract][Full Text] [Related]
13. Exogenous PTHrP Repairs the Damaged Fracture Healing of PTHrP+/- Mice and Accelerates Fracture Healing of Wild Mice. Wang Y; Fang X; Wang C; Ding C; Lin H; Liu A; Wang L; Cao Y Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28178186 [TBL] [Abstract][Full Text] [Related]
14. Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice. Li M; Healy DR; Li Y; Simmons HA; Crawford DT; Ke HZ; Pan LC; Brown TA; Thompson DD Bone; 2005 Jul; 37(1):46-54. PubMed ID: 15869929 [TBL] [Abstract][Full Text] [Related]
15. Rescue of impaired fracture healing in COX-2-/- mice via activation of prostaglandin E2 receptor subtype 4. Xie C; Liang B; Xue M; Lin AS; Loiselle A; Schwarz EM; Guldberg RE; O'Keefe RJ; Zhang X Am J Pathol; 2009 Aug; 175(2):772-85. PubMed ID: 19628768 [TBL] [Abstract][Full Text] [Related]
16. Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro. Tomita M; Li X; Okada Y; Woodiel FN; Young RN; Pilbeam CC; Raisz LG Bone; 2002 Jan; 30(1):159-63. PubMed ID: 11792579 [TBL] [Abstract][Full Text] [Related]
17. TRPV1 deletion impaired fracture healing and inhibited osteoclast and osteoblast differentiation. He LH; Liu M; He Y; Xiao E; Zhao L; Zhang T; Yang HQ; Zhang Y Sci Rep; 2017 Feb; 7():42385. PubMed ID: 28225019 [TBL] [Abstract][Full Text] [Related]